Cardinal Health Reaffirms Fiscal 2024 non-GAAP EPS Guidance and Long-term Targets Amidst Nonrenewal of OptumRx Customer Contracts
Go back to Cardinal Health Reaffirms Fiscal 2024 non-GAAP EPS Guidance and Long-term Targets Amidst Nonrenewal of OptumRx Customer Contracts| Cardinal Health Inc. (NYSE: CAH) | Delayed: 244.76 -1.69 (0.69%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $246.45 | 52 Week High | $91.22 | |||
| Open | $243.91 | 52 Week Low | $62.70 | |||
| Day High | $247.14 | P/E | 228.75 | |||
| Day Low | $243.49 | EPS | $1.07 | |||
| Volume | 1,102,256 | |||||



